1. Market Research
  2. > Healthcare Market Trends
  3. > Review of the Healthcare System and Medical Device Market in the Philippines – report

This TforG Healthcare Market review report for the Philippines includes numerical and written analysis on the socioeconomic and macroeconomic context and outlook, the healthcare system, and the latest healthcare reforms. Moreover, an extensive chapter is dedicated to the markets for capital equipment, medical devices, disposables and pharmaceuticals.

The report helps businesses gain a unique insight into the socio-economic dynamics, and helps analyze how they affect healthcare systems and their evolution. It can serve as a valuable tool with actionable guidance for sales, marketing, R&D and business managers with industry related interests.

Four chapters cover the numerical and written analysis for the following topics: Economic Outlook (38 Key industry indicators), The Healthcare System (HC system structures), Reforms (restructuring, re-engineering or austerity efforts) and the Healthcare Market (Capital Equipment, Medical Devices, Disposables and Pharmaceuticals).

Economic Outlook:
- GDP growth rate has remained stable from 2014 to 2015 at a rate of 6.5 percent. The GDP is composed of 10.7 percent from the agricultural sector, 31.5 percent from industry, and 57.8 percent from the service sector.
-The Philippines has demonstrated a strong sense of sustainability and economic vigor, after overcoming the devastation of the typhoon two years ago. Despite such a set-back, the average economic growth rate has been over 5 percent in the past 5 years.
-The current inflation rate lies at 3.3 percent, which is a gentle increase from previous years.
-The current unemployment rate is 7.1 percent.
-The Philippines have a credit rating of BBB, stable.
-The Philippine economy is in transition from agriculture based to manufacturing and services. It is forecasted that it will become the largest economy in Southeast Asia, the 5th largest economy in all of Asia, and the 16th largest economy of the world in the coming decades.

The Healthcare System:
-Healthcare spending in 2014 was 4.65 percent of GDP. The average spending of OECD nations is 9.3 percent of their GDP.
- 37.79 percent of healthcare spending is paid for through public health expenditure, and 62.2 percent via private health expenditure.
-The private sector is larger than the public sector in many regards, from human and financial capital to technological resources.
-There is a low level of financial protection and medical expense reimbursement from the national public insurance provider PhilHealth further trouble the equality of health provision.
-The Philippines rank 9th in the list of countries where TB is most extensive.
-The Philippines have made great progress in the past decades tackling infant mortality; the rate dropped by over 50% in the last 25 years.
-In 2013, of the total health costs paid for, 48.9 percent was financed by out-of-pocket payments, PhilHealth provided 11.1 percent, local governments coverd 13.32 percent, and the national government financed 15.54 percent. The remaining 11.1 percent fall under the other category, which includes a large share of charity contributions.

- Kalusugan Pangkalahatan (KP), or Universal Health Care, under the National Health Insurance Act (2013) This reform extends healthcare insurance coverage to include the poorest classes, via government subsidies, develop benefit packages and to remove co-payments
-Increasing bed capacity and public health facilities
-The Department of Health national objectives and the Aquino Health Agenda.
These objectives and reforms seek to provide financial risk protection, through expansion of the National Health Insurance Program and to improve access to healthcare and quality hospitals and facilities.

The Markets:
-The medical device and product market is currently worth around 500 m Euro, including medical consumables (21.9 percent), diagnostic imaging (35.8 percent), orthopedics and implants (3.2 percent), dental products (8.6 percent), auxiliary devices (9.1 percent) and other medical devices (21.5 percent).
-The pharmaceutical industry was worth approximately 145.05 bln PHP (2.85 bln Euro) in 2014. It is estimated to increase by 3.5 percent in local currency by 2015, equivalent to a total worth of 2.95 bln Euro.
-The Philippine medical industry is largely dependent upon foreign imports.
-Over 80 percent of medication sold in the Philippines is done through retail pharmacies.
-Both local and foreign generic manufacturers are quickly gaining larger market shares.
-National Public-Private Partnership program calling for support and business opportunities with private entities.

Reasons to buy:
– Accurate analysis of trends, opportunities and challenges of the economy and healthcare industry
– Relevant healthcare reforms
– Written and numerical analysis on important healthcare indicators (eg.: acute care data, critical care data, anesthesia data, emergency data, healthcare professionals)
– Regularly updates, at least once year
– Every update published by TforG within 6 months after your purchase will be made available to you
– Global coverage, available for + 40 countries
– Unique insight into the socio-economic dynamics, and analysis of their effect on healthcare systems

Table Of Contents

Review of the Healthcare System and Medical Device Market in the Philippines - report
1.0 Executive Summary
2.0 Socioeconomic Outlook
2.1 Socioeconomic Context
2.2 Macroeconomics
2.3 Table 1.1 - Macroeconomics (2012-2017)
2.4 Economic Outlook
3.0 The Philippine Healthcare System
3.1 Introduction
3.2 Healthcare Status
3.3 Healthcare Expenditures
3.4 Table 2.1 - Healthcare (2011-2017)
3.5 The Organization
3.6 Federal Level
3.7 Regional Level
3.8 Local Level
3.9 Diagram 2.1 - Healthcare Organization (2015)
3.10 Primary Care
3.11 Secondary Care
3.12 Table 2.2 - Secondary Care (2014)
3.13 Tertiary Care
3.14 Healthcare Insurance
3.15 Healthcare Financing
3.16 Financial Flows
3.17 Diagram 2.2 - Financial Flow (2015)
3.18 Private versus Public
4.0 Healthcare Reforms
4.1 Current Challenges
4.2 Recent Reforms
4.3 Hospital Operations and Priorities
5.0 The Markets
5.1 Market Profile
5.2 Purchase Processes and Decision-Making
5.3 Pharmaceuticals
5.4 Capital Equipment
5.5 Medical Devices
5.6 Medical Disposables
5.7 Opportunities and Market Drivers
6.0 Country Overview
6.1 Demographics, Macroeconomics and Healthcare
7.0 National Care Provision Data
7.1 Acute Care Data
7.2 Critical Care
7.3 Anesthesia
7.4 Emergency
7.5 Hospital Services Data
7.6 Healthcare Professionals
8.0 The TforG Methodology
8.1 Primary Research
8.2 Secondary Research
8.3 Our Experience

Companies Mentioned
TOMI Environmental Solutions, Espire Health, Novartis, GlaxoSmithKline, Sanofi, Bristol Myers Squibb, Johnson and Jonson, Abbott Laboratories, AstraZeneca, Pfizer, Interphil Laboratories, Natrapharm, Pascual Laboratories, GV International, United Laboratories, Metro Drug, and Zuellig Pharma

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Healthcare IT Market by Product End User - Global Forecast to 2021

Healthcare IT Market by Product End User - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

  • $ 7150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.